Biogen licenses a stroke drug from Japanese drugmaker TMS
Bio Pharma Dive
MAY 12, 2021
The drug, which Biogen had an option to license, is one of two in the biotech's pipeline for a condition that has had few new treatments developed.
Wed.May 12, 2021
246 
New Cell Therapy Shows Promise in Treating HIV
BioSpace
MAY 12, 2021
At the Seraph Research Institute, scientists presented new research at the 2021 ASGCT that shows promise in treating HIV.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CDC panel to vote on Pfizer vaccine for 12- to 15-year-olds
Bio Pharma Dive
MAY 12, 2021
The Advisory Committee on Immunization Practices is likely to recommend use of the shot among young teens after an FDA authorization earlier this week.
Alvotech files lawsuit challenging AbbVie’s Humira patent thicket
pharmaphorum
MAY 12, 2021
Biosimilars firm Alvotech has filed a lawsuit that challenges AbbVie’s legal defences surrounding the inflammatory disease drug Humira in the US. Alvotech is challenging the patent thicket surrounding Humira, a common ploy in pharma that seems to be particularly effective in the US. Several biological drugs have remained unchallenged on the US market thanks to a legal force-field from supplementary patents, after the main patent has expired and after protection has lapsed in Europe and other cou
Top customer engagement trends in pharma
Bio Pharma Dive
MAY 12, 2021
The future of provider and patient engagement in healthcare.
Symbiotic bacteria in root cells may be key to producing better crops, Rutgers study finds
Scienmag
MAY 12, 2021
Credit: Rutgers University-New Brunswick New Brunswick, N.J. (May 12, 2021) – A Rutgers study finds that symbiotic bacteria that colonize root cells may be managed to produce hardier crops that need less fertilizer. The study appears in the journal Microorganisms. Bacteria stimulate root hair growth in all plants that form root hairs, so the researchers […].
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Decoding the Trends in COVID-19 Variants: Vaccines and Regions of Concern
BioSpace
MAY 12, 2021
New mutations of the SARS-CoV-2 virus are continuing to be discovered. As we’ve seen from the most common variants of the virus, infectiousness appears to be the trait most familiar to all of them.
NICE says ‘no’ to Pfizer’s Vyndaqel for rare heart condition
pharmaphorum
MAY 12, 2021
NICE has rejected regular NHS funding for Pfizer’s Vyndaqel (tafamidis) for a rare heart condition, although it has left the door open for negotiations if the pharma decides to drop its price. Pfizer had appealed against draft guidance from NICE that rejected Vyndaqel for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) on cost grounds. The pharma unsuccessfully appealed against the decision in first draft guidance issued in June last year, along with patient associations Cardiomyopathy U
'Connectivity is a key enabler for continuous manufacturing'
BioPharma Reporter
MAY 12, 2021
Connectivity of unit operations is a key enabler for continuous manufacturing to deliver benefits of not only improved mass throughput, but ultimately reduced COGS and increased facility utilization, says Merck.
Birdie raises $11.5m to develop care at home app
pharmaphorum
MAY 12, 2021
The care technology firm Birdie has raised $11.5 million to develop its app to help providers deliver elderly care at home. In a statement the UK firm said the fundraiser led by international VC Index Ventures and with participation from Kamet Ventures will be used to grow its business and develop its product. Birdie said its app can help care providers to efficiently deliver more coordinated, personalised and preventative care.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Celevac discontinued: What are Celevac alternatives?
Druggist
MAY 12, 2021
Are you are one of few last patients who still get Celevac prescribed? Unfortunately, Celevac was discontinued , and now it is impossible to get it on prescription or purchase from the pharmacy. In this post, I will briefly review the use of Celevac,:what it is and talk about alternative options (prescription and over the counter products) which have similar use to Celevac.
3 Key Goals the Life Science Industry Must Focus on in 2021
XTalks
MAY 12, 2021
As the world plans its recovery from the setbacks imposed by the COVID-19 pandemic, industries are looking to apply lessons learned from the past year and improve business operations going forward. In the life sciences, like many industries, working from home will likely remain more prevalent than it was pre-pandemic even after it’s safe for employees to return to the office.
Emergent Bio Execs to Testify Before Congress Following Vaccine Manufacturing Mistake
BioSpace
MAY 12, 2021
Emergent company executives Fuad El-ibri and Robert Kramer will be testifying before a congressional probe after a botched batch of 15 million doses of J&J’s COVID-19 vaccine.
Research team investigates causes of tuberous sclerosis
Scienmag
MAY 12, 2021
Mutations can disrupt protein binding through a “burr effect” thus interfering with the regulation of cell growth Credit: Kümmel team/Oeckinghaus team Tuberous Sclerosis Complex (TSC) affects between one and two of every 10,000 new-born babies. This genetic disease leads to the formation of benign tumours which can massively impair the proper functioning of vital organs […].
Going to Work Could be Safer than Staying Home in a Pandemic, U of Chicago Study Finds
BioSpace
MAY 12, 2021
Staying at home during the COVID-19 pandemic actually increased the spread of infection, according to new study published by the University of Chicago and, soon, by the National Bureau of Economic Research.
Research reveals ancient people had more diverse gut microorganisms
Scienmag
MAY 12, 2021
Credit: UM photo by Tommy Martino MISSOULA – Only an anthropologist would treasure millennia-old human feces found in dry caves. Just ask Dr. Meradeth Snow, a University of Montana researcher and co-chair of UM’s Department of Anthropology. She is part of an international team, led by the Harvard Medical School-affiliated Joslin Diabetes Center, that used […].
How Thinking Like a Salesperson Can Help You Land Your Dream Job
BioSpace
MAY 12, 2021
The moment you step on the job market, you’re selling yourself. Yes, you, the job seeker, are a “brand,” and each touchpoint you have with a potential new employer is an opportunity to “sell” that brand, that vision of your candidacy, the promise of yourself as a future team member and employer.
Previously unknown letter reveals Einstein’s thinking on bees, birds and physics
Scienmag
MAY 12, 2021
A recently discovered letter written by Albert Einstein discusses a link between physics and biology, seven decades before evidence emerges. Credit: Dyer et al. 2021, J Comp Physiol A / The Hebrew University of Jerusalem The 1949 letter by the physicist and Nobel laureate discusses bees, birds and whether new physics principles could come from […].
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
U.S. Public Health Agencies Face Increasing Credibility Concerns During Pandemic
BioSpace
MAY 12, 2021
Comments on social media provide a glimpse at the deep divide in trust of public health agencies, and now a new survey demonstrates the breadth of that distrust.
C-Path announces accelerated data sharing collaboration with Tufts Medical Center
Scienmag
MAY 12, 2021
FDA grant supports use of real-world data to generate real-world evidence in neonates Credit: C-Path TUCSON, Ariz., May 12, 2021 — Critical Path Institute (C-Path) and Tufts Medical Center have announced a joint venture to integrate the first patient-level clinical trial data to generate actionable real-world evidence (RWE) for neonatal drug development, from real-world neonate […].
No Chemicals, Heat or Irradiation Needed for Aphios’ Viral Inactivation Tech
BioSpace
MAY 12, 2021
Aphios International is developing a generally applicable pathogen reduction technology for pooled blood plasma and blood products, immunoglobulins, recombinant biologics and monoclonal antibodies used to treat cancer and COVID-19 patients.
Lilly buys into MiNA’s protein-boosting RNA tech in $1.25bn deal
pharmaphorum
MAY 12, 2021
UK biotech MiNA Therapeutics has signed up another big pharma partner for its small activating RNA (saRNA) platform, which upregulates the activity of proteins, with Eli Lilly the latest to get in on the action. . While most RNA-based drugs are intended to reduce the activity of proteins that are over-expressed, saRNAs work in the opposite way, amplifying the expression of proteins which are not produced in sufficient amounts.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Israeli Company Grabs $28.5 Million for Restorative Cystic Fibrosis Treatment
BioSpace
MAY 12, 2021
SpliSense, which focuses on cystic fibrosis and other genetic pulmonary diseases, closed on a $28.5 million Series B financing round. The company plans to use the money to advance its pipeline.
Research predicts the post-COVID landscape for HCP engagement
pharmaphorum
MAY 12, 2021
IQVIA’s Liz Murray takes us through the company’s latest research into HCPs’ attitudes to pharma engagement, and asks how pharma sales forces can adapt for future changes. This article appears in full in Deep Dive: Market Access 2021. Read a preview below: Recent ChannelDynamics data from IQVIA shows that while there has been a marked positive change in HCPs’ views of remote rep platforms over the past 12 months, there has not actually been much change in their views of face-to-face engagement,
NICE rejects Pfizer’s rare heart disease treatment Vyndaqel
Pharma Times
MAY 12, 2021
The final guidance publication comes following an appeal against earlier draft recommendations
A new visual library to achieve successful Plus Energy Building design
Scienmag
MAY 12, 2021
Mapping culture and climatic energy drivers in Europe Credit: Cultural-E project Researchers from RMIT University, Eurac Research and University Ca’ Foscari Venezia have launched an innovative GIS map with a difference: The European Climate and Cultural Atlas for Plus Energy Building Design – the 2CAP-Energy Atlas. The Atlas has been developed as part of the […].
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
New NHS legislation provides ‘once-in-a-decade opportunity’ to centre research
Pharma Times
MAY 12, 2021
Pharma industry and health leaders react to new legislation and plans outlined in the Queen’s Speech
Polypharmakos and CABI to develop new antimicrobial products from CABI Culture Collection
Scienmag
MAY 12, 2021
Polypharmakos Limited, a spin-out company from the Royal Botanic Gardens Kew and University of Cambridge, and international not-for-profit organisation CABI have signed a research collaboration and licensing agreement to develop novel products from Credit: CABI Polypharmakos Limited, a spin-out company from the UK’s Royal Botanic Gardens Kew and University of Cambridge, and international not-for-profit organisation […].
A Look Into Telehealth in 2021 and Beyond
Pharma Marketing Network
MAY 12, 2021
According to a stat by Medgadget, “Global Telemedicine Market is valued at USD 27.04 Billion in 2019 and Expected to Reach USD 171.81 Billion by 2026 with a CAGR of 37.2% over the Forecast Period.”. The COVID-19 pandemic seriously accelerated the adoption and implementation of telehealth services, like remote patient monitoring and out-of-office “visits” – a trend that was already on the incline.
Sources of SARS-CoV-2 and other microorganisms in dental aerosols
Scienmag
MAY 12, 2021
Alexandria, Va., USA — COVID-19 was declared a global pandemic in March 2020 and given an incomplete understanding of the transmission of SARS-CoV-2 at that time, the American Dental Association recommended that dental offices refrain from providing non-emergency services. As a result, 198,000 dentists in the United States closed their doors to patients.
Roles and Responsibilities of Specialized Clinical Supply Experts
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Let's personalize your content